Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Droxicam-induced toxic hepatitis]

M Berenguer1, F Pérez-Aguilar, C Gisbert

  • 1Servicio de Medicina Digestivo, Hospital La Fe, Valencia.

Revista Espanola De Enfermedades Digestivas
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.

Alimentary pharmacology & therapeutics·2024
Same author

Sustainable cultivation of melon landraces: Effects of grafting on the accumulation of flavor-related compounds.

Food chemistry·2024
Same author

Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt - TIPS, and strategies to improve the outcomes.

Acta gastro-enterologica Belgica·2023
Same author

Neutralizing antibodies for SARS-CoV-2 infection.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022
Same author

Effect of HCV eradication on critical flicker frequency in HIV/HCV coinfected patients with advanced cirrhosis.

Revista clinica espanola·2022
Same author

ARAMIS: From systematic errors of NGS long reads to accurate assemblies.

Briefings in bioinformatics·2021

Droxicam use was linked to four cases of hepatitis, including acute and chronic forms. Following its withdrawal, Droxicam is no longer considered a cause of drug-induced liver injury.

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Drug-Induced Liver Injury

Background:

  • Droxicam, a non-steroidal anti-inflammatory drug (NSAID), has been investigated for potential adverse effects.
  • Hepatotoxicity is a known, albeit rare, complication associated with NSAID use.

Observation:

  • Four patients presented with hepatitis, exhibiting clinical features strongly suggesting a direct association with Droxicam.
  • The clinical course involved acute hepatitis with resolution in most cases.
  • One patient progressed to develop autoimmune chronic active hepatitis.

Findings:

  • Comprehensive diagnostic evaluations, including ultrasound, liver biopsy, and serologic markers, confirmed the hepatitis diagnoses.
  • The observed liver injuries were directly attributed to Droxicam exposure.

Related Experiment Videos

Implications:

  • Regulatory action led to the postponement of Droxicam dispensation in Spain from February 25, 1995.
  • Droxicam should be excluded as a potential cause of acute or chronic hepatitis in future clinical considerations.
  • This case series highlights the importance of post-marketing surveillance for identifying drug-induced liver injury.